Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Wuxi Zhufeng Fine Chemical is a Chinese specialty chemical manufacturer and exporter focused on bactericides, cosmetic preservatives, flame-retardant synergists, and certain medical intermediates. Company materials describe products including sodium pyrithione, ethylhexylglycerin, 1,2-octanediol, caprylyl glycol, and dicumene, with sales into Europe, the United States, East Asia, and China. The business appears to operate primarily as an industrial and personal-care ingredient supplier rather than a drug developer, with ISO 9001 certification and some products reported as REACH registered. Although some directories mention medical intermediates and botanical components, there is no clear evidence of a therapeutic pipeline or clinical-stage biopharma activity. Overall, it is best characterized as a commercial fine chemicals company serving cosmetics, industrial preservation, coatings, and related applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Wuxi Zhufeng Fine Chemical.